RecruitingNot ApplicableNCT07521930

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)

Sponsor

Johns Hopkins University

Enrollment

5 participants

Start Date

Sep 1, 2026

Study Type

INTERVENTIONAL

Conditions

Spinal Cord Injuries (SCI)Amyotrophic Lateral Sclerosis(ALS)Muscular Dystrophies Tetraplegia/Tetraparesis Muscular Disorders, Atrophic Brain Stem Stroke Muscular Atrophy, Progressive Pontine Hemorrhage Pontine Infarction

Summary

The goal of this clinical trial is to evaluate the safety and preliminary efficacy of an implantable device that records and stimulates different areas of the brain to allow adults affected by disabling paralysis (see Eligibility for more details) to control and receive feedback from assistive devices.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called INTENT Neural Interface System for people with amyotrophic lateral sclerosis(als), brain stem stroke, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEINTENT Neural Interface System

Up to eight microelectrode arrays will be implanted on motor, sensory, and integrative cortex, connected to up to three percutaneous pedestals. Neural recording and stimulation will occur during study visits that will occur at least weekly and up to five days per week throughout the study.